- Report
- September 2022
- 40 Pages
France
From €1365EUR$1,500USD£1,160GBP
- Report
- September 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- September 2022
- 40 Pages
Brazil
From €1365EUR$1,500USD£1,160GBP
- Report
- September 2021
- 40 Pages
United States
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2024
- 83 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- May 2023
- 83 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- September 2022
- 80 Pages
Africa
From €1820EUR$2,000USD£1,546GBP
Alpha emitters are a type of radioactive material used in nuclear medicine and radiopharmacology. They are used to diagnose and treat diseases such as cancer, and are typically administered to patients through intravenous injections. Alpha emitters are composed of short-lived, high-energy particles that can be used to target and destroy cancer cells. They are also used in research to study the effects of radiation on cells and tissues.
The alpha emitter market is a rapidly growing sector of the nuclear medicine and radiopharmacology industry. It is driven by the increasing demand for more effective treatments for cancer and other diseases. The market is expected to continue to grow as new technologies and treatments are developed.
Some of the major companies in the alpha emitter market include Nordion, Eckert & Ziegler, and IBA Molecular. These companies specialize in the production and distribution of alpha emitters for medical and research applications. Show Less Read more